Literature DB >> 15766340

Cardiopulmonary bypass temperature and brain function.

M Shaaban Ali1, M Harmer, F Kirkham.   

Abstract

A debate has emerged in recently published studies about the optimum cardiopulmonary bypass temperature for good neurological outcome - warm vs. cold, i.e. normothermic vs. hypothermic. Although many comparative studies have been performed, the results of these studies are inconclusive and are difficult to interpret. Brain function has been studied in terms of neurological and neuropsychological outcome, protein S100beta levels as a marker of brain damage, and cerebral oxygenation using jugular bulb oximetry and near-infrared spectroscopy. The studies produce no conclusive proof of the superiority of warm or cold cardiopulmonary bypass. However, it appears that any degree of bypass hypothermia (< 35 degrees C) may protect the brain. On the other hand, even a slight increase in bypass temperature to > 37 degrees C may cause marked brain injury.

Entities:  

Mesh:

Year:  2005        PMID: 15766340     DOI: 10.1111/j.1365-2044.2005.04112.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

1.  Effect of slow versus rapid rewarming on jugular bulb oxygen saturation in adult patients undergoing open heart surgery.

Authors:  Mohmaed Shaaban Ali; Sameh Abd Al Rhman Sayed; Maged Salah Mohamoud; Sayed Kaoud Abd-Elshafy; Mohamed Gomaa Almaz
Journal:  Saudi J Anaesth       Date:  2014-04

2.  Effects of 4 major brain protection strategies during aortic arch surgery: A protocol for a systematic review and network meta-analysis using Stata.

Authors:  Shulei Fan; Daoxing Wang; Chun Wu; Zhengxia Pan; Yonggang Li; Yong An; Hongbo Li; Gang Wang; Jiangtao Dai; Quan Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

3.  Effect of memantine on post-operative cognitive dysfunction after cardiac surgeries: a randomized clinical trial.

Authors:  Saba Ghaffary; Padideh Ghaeli; Azita Hajhossein Talasaz; Abbasali Karimi; Maryam Noroozian; Abbas Salehiomran; Arash Jalali
Journal:  Daru       Date:  2017-11-21       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.